Answers are grounded in this paper and cite their sources.
CAZ-AVI appears to be a promising drug for treatment of severe KPC-Kp infections, especially those involving bacteremia.
No takes yet. Share an insight, caveat, or question.
Tumbarello et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: